Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin’s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin’s first FDA approved product and is available in the United States by prescription. For more information about Vascepa visit www.vascepa.com.
For more information, visit www.amarincorp.com and follow us on www.twitter.com/amarincorp.
See our Community Guidelines: bit.ly/2L7xEW6
Company’s Keywords:
cardiovascular
660
pharmaceuticals
535647000
Cloudflare DNS, Rackspace MailGun, Outlook, Microsoft Office 365, CloudFlare Hosting, New Relic, Google Analytics, Mobile Friendly, Bootstrap Framework, Google Font API, ASP.NET, Google Tag Manager
1991